![Emile Loria](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emile Loria
Gründer bei
Dendrogenix SA
Vermögen: 12 Mio $ am 31.05.2026
Profil
Emile Loria is the founder of Ms Medical Synergy SA, founded in 1986.
Dr. Loria was the founder of Orphan Synergy Europe-Pharma SA, founded in 2004, and held the title of Chairman.
Dr. Loria was the founder of OSE Immunotherapeutics SA, founded in 2012, and held the title of Chairman from 2012 to 2018.
Dr. Loria is the founder of Dendrogenix SA, founded in 2018, and holds the title of Director.
Dr. Loria is currently the Chairman & President of Portable Genomics, Inc. Former positions include President & Chief Executive Officer at Epimmune, Inc. from 2001 to 2005, Principal at Sanofi, Principal at Novartis Corp., Principal at Biovector Therapeutics SA, and President at IDM Pharma, Inc. from 2001 to 2006.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.09.2025 | 2’287’616 ( 10.09% ) | 12 Mio $ | 31.05.2026 |
Aktive Positionen von Emile Loria
| Unternehmen | Position | Beginn |
|---|---|---|
Portable Genomics, Inc. | Vorsitzender | - |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Gründer | 01.01.2018 |
Ehemalige bekannte Positionen von Emile Loria
| Unternehmen | Position | Ende |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Gründer | 03.01.2018 |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Präsident | 09.01.2006 |
Epimmune, Inc.
 Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | Präsident | 17.08.2005 |
Ms Medical Synergy SA
 Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Gründer | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Epimmune, Inc.
Epimmune, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to treat and prevent infectious diseases and cancer | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Biovector Therapeutics SA
 Biovector Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops products for prevention and treatment of infectious disease and cancer | Health Technology |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Ms Medical Synergy SA
Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Portable Genomics, Inc. | |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Health Technology |
